Covered recipient · General Payments record
SHADI MILANI-NEJAD
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,830.92
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $555.62 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ARGENX US, INC. | $241.60 | 8 |
| CSL Behring | $124.51 | 1 |
| UCB, Inc. | $69.73 | 2 |
| Alexion Pharmaceuticals, Inc. | $45.24 | 2 |
| ABBVIE INC. | $37.17 | 2 |
| PFIZER INC. | $20.30 | 1 |
| Inspire Medical Systems, Inc. | $17.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.52 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105034141 | CMS |
| ABBVIE INC. | $16.65 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105034143 | CMS |
| Alexion Pharmaceuticals, Inc. | $23.31 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093939292 | CMS |
| Alexion Pharmaceuticals, Inc. | $21.93 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094017293 | CMS |
| ARGENX US, INC. | $15.02 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142106888 | CMS |
| ARGENX US, INC. | $16.04 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142108607 | CMS |
| ARGENX US, INC. | $9.53 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142112725 | CMS |
| ARGENX US, INC. | $120.96 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142116158 | CMS |
| ARGENX US, INC. | $15.49 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142123445 | CMS |
| ARGENX US, INC. | $13.29 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142119719 | CMS |
| ARGENX US, INC. | $34.98 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142119843 | CMS |
| ARGENX US, INC. | $16.29 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142118642 | CMS |
| CSL Behring | $124.51 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134605815 | CMS |
| Inspire Medical Systems, Inc. | $17.07 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148083173 | CMS |
| PFIZER INC. | $20.30 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131577186 | CMS |
| UCB, Inc. | $32.42 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143093223 | CMS |
| UCB, Inc. | $37.31 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143093225 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.